Thus, maintaining appropriate levels of arterial and cardiac VASN could be an innovative therapeutic strategy to prevent adverse cardiovascular remodeling elicited by inflammation, fibrosis, and calcification, as well as associated cardiovascular diseases such as hypertension, atherosclerosis, and heart failure. The gene discussed is VASN; the disease is heart failure.